Clinical outcome of SARS-CoV-2 infection in 7 adults with Duchenne muscular dystrophy attending a specialist neuromuscular centre.


Journal

Neuromuscular disorders : NMD
ISSN: 1873-2364
Titre abrégé: Neuromuscul Disord
Pays: England
ID NLM: 9111470

Informations de publication

Date de publication:
07 2021
Historique:
received: 18 01 2021
revised: 16 04 2021
accepted: 19 04 2021
pubmed: 30 5 2021
medline: 10 8 2021
entrez: 29 5 2021
Statut: ppublish

Résumé

Due to their frailty and cardiorespiratory compromise adults with DMD are considered extremely vulnerable and at high risk of severe infection should they contract COVID-19. We report 7 adults with DMD aged 17-26 years who tested positive on a nasopharyngeal PCR swab for SARS-CoV-2. Despite long term corticosteroid treatment, severe respiratory compromise requiring night-time ventilation and receiving treatment for moderate to severe cardiomyopathy, none of the patients developed moderate to severe symptoms; in fact two remained asymptomatic and two developed only anosmia and reduced sensation. The remaining three developed transient fever with or without sore throat, cough and runny nose. All recovered fully without complication and no patient required hospitalization.

Identifiants

pubmed: 34049779
pii: S0960-8966(21)00102-4
doi: 10.1016/j.nmd.2021.04.005
pmc: PMC8076729
pii:
doi:

Substances chimiques

Adrenal Cortex Hormones 0

Types de publication

Case Reports Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

603-606

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Lancet Neurol. 2018 Mar;17(3):251-267
pubmed: 29395989
J Neurol. 2021 Sep;268(9):3081-3085
pubmed: 33387010
Lancet Neurol. 2018 Apr;17(4):347-361
pubmed: 29395990
Neurology. 2020 Jun 2;94(22):959-969
pubmed: 32284362
Clin Cardiol. 2020 Dec;43(12):1478-1493
pubmed: 33026120
Lancet Neurol. 2018 May;17(5):445-455
pubmed: 29398641
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076

Auteurs

Ros Quinlivan (R)

Neuromuscular Complex Care Centre, National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom; MRC Centre for Neuromuscular Disease, UCL Institute of Neurology, London, United Kingdom. Electronic address: r.quinlivan@ucl.ac.uk.

Mahalekshmi Desikan (M)

Neuromuscular Complex Care Centre, National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom.

Francis Cruces (F)

Neuromuscular Complex Care Centre, National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom.

Aleksandra Pietrusz (A)

MRC Centre for Neuromuscular Disease, UCL Institute of Neurology, London, United Kingdom.

Konstantinos Savvatis (K)

Neuromuscular Complex Care Centre, National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom; Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH